Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Capital Employed (2016 - 2025)

Enanta Pharmaceuticals' Return on Capital Employed history spans 13 years, with the latest figure at 0.28% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 7.0% year-over-year to 0.28%; the TTM value through Dec 2025 reached 0.28%, up 7.0%, while the annual FY2025 figure was 0.3%, 3.0% up from the prior year.
  • Return on Capital Employed reached 0.28% in Q4 2025 per ENTA's latest filing, up from 0.35% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.19% in Q1 2021 to a low of 0.42% in Q1 2023.
  • Average Return on Capital Employed over 5 years is 0.34%, with a median of 0.35% recorded in 2025.
  • Peak YoY movement for Return on Capital Employed: dropped -21bps in 2021, then rose 7bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.32% in 2021, then decreased by -15bps to 0.36% in 2022, then decreased by -2bps to 0.37% in 2023, then grew by 5bps to 0.35% in 2024, then rose by 20bps to 0.28% in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Return on Capital Employed are 0.28% (Q4 2025), 0.35% (Q3 2025), and 0.36% (Q2 2025).